Smith & Nephew plc SN.

LON: SN. | ISIN: GB0009223206   12/09/2025
1.405,00 GBX (-1,30%)
(-1,30%)   12/09/2025
Grafiek Smith & Nephew plc Grafiek Smith & Nephew plc

Smith & Nephew plc in het nieuws

11 september 2025 · Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant · Persbericht

7 juli 2025 · Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option · Persbericht

29 juni 2025 · Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair · Persbericht

24 juni 2025 · Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures · Persbericht

23 juni 2025 · Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer · Persbericht

18 juni 2025 · Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK · Persbericht

9 juni 2025 · New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility · Persbericht

27 mei 2025 · Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense   · Persbericht

14 mei 2025 · A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients · Persbericht

7 mei 2025 · Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹* · Persbericht

Profiel Smith & Nephew plc

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van chirurgische apparatuur

Mijn selecties